MEDICAL ADVISORS

KYLE ANDERSON, M.D.

Associate Professor of Urology, University of Minnesota

Dr. Anderson is an Associate Professor of Urology at the University of Minnesota where he specializes in minimally-invasive treatments of both prostate and kidney cancer and has researched thermal and cryo-therapies. Dr. Anderson rotates between the University of Minnesota Medical Center and the V.A. Medical Center where he treats BPH and cancer patients. His understanding of BPH, experience in researching ablative technologies, and relationships with both the University and V.A. Medical Center are quite beneficial in assisting Ionix Medical with system design and clinical trials.

MARK FALLEN, M.D.

Partner, Urologic Physicians P.A.

Dr. Fallen is an expert in treating benign prostatic hyperplasia (BPH) with minimally invasive techniques. He completed his premedical education at Northern Illinois University in Dekalb. He received his medical training at Rush Medical College in Chicago. His internship and urology residency were carried out at the Mayo Clinic in Rochester, Minnesota. Dr. Fallen has authored a number of presentations and publications.

SOLOMON HAMBURG, M.D. Ph.D.

Clinical Associate Professor of Medicine, UCLA Medical School

Dr. Hamburg is also Clinical Co-Director of the Blood and Marrow Transplant Program at Cedars-Sinai Medical Center. He received a doctorate from the NYU Graduate School of Arts and Sciences and his medical degree from the NYU School of Medicine. Board certified in internal medicine, hematology and medical oncology, Dr. Hamburg's interests include bone marrow transplantation, oncological and hematological complications of organ transplantation, lung cancer, lymphoma, and brain tumors. He has published articles in numerous peer-reviewed journals, including Hematology, Cell Immunology and the Journal of Immunology.

THAYNE LARSON, M.D.

Institute of Medical Research and Scottsdale Mayo Department of Urology

Dr. Larson is an accomplished researcher in the area of minimally-invasive treatments for BPH. He has performed and coordinated multiple clinical studies, using many competitive BPH technologies including Prostiva, Prolieve, CoreTherm, TherMatrx, and Targis.

THOMAS TAYLOR, M.D.

Clinical Professor of Surgery at Baylor College of Medicine and University of Texas and Chief of Surgery, St. Joseph Medical Center, Houston, Texas

Dr. Taylor received his M. D. from the Manchester University Medical School and is a Fellow of the American College of Gastroenterology and the American College of Surgeons. Awards include the Moynihan Prize and Medal for the best research presented to the Association of Surgeons of Great Britain and being named Hunterian Professor, Royal College of Surgeons. Dr. Taylor has authored and edited several books and lists over 260 publications, many reporting his studies on the use of DC ablation in animals and in human patients with esophageal cancer, Kaposi's sarcoma, etc.